Slides
Page 1
Delivering Performance Q2 FY27 Earnings Presentation Sustaining Trust Creating Value November 2026
Page 2
2 Safe Harbor Certain statements in this document may be forward-looking statements. Such forward looking statements are subject to certain risks and uncertainties like regulatory changes, local political or economic developments, and many other factors that could cause our actual results to differ materially from those contemplated by the relevant forward-looking statements. Neogen Chemicals Limited will not be in any way responsible for any action taken based on such statements and undertakes no obligation to publicly update these forward-looking statements to reflect subsequent events or circumstances.
Page 3
3 Table of Contents 3 Q2 FY27 Financial Performance & Expansion Initiatives Introduction to Neogen Chemicals Industry Overview: Lithium-Ion Batteries Way Forward Sustainability & CSR Initiatives Contact Us 01 02 03 04 05 06
Page 4
4 Q2 FY27 Financial Performance & Expansion Initiatives
Page 5
5 5 INR in crore Standalone Consolidated Revenues 39% | 288 42% | 296* Gross Profit 27% | 121 36% | 133 EBITDA 54% | 54 51% | 45 PAT 127% | 21 144% | 8 Note: Growth for Q2 FY27 is compared to Q2 FY26 Performance Highlights – Q2 FY27 Q2 FY27 Revenue break-up** 66% 34% Domestic *Exports *Including deemed exports **Consolidated figures 80% 20% Organic Inorganic * Consolidated Revenues include INR 37 crore from Battery Chemicals
Page 6
6 207 288 Q2 FY26 Q2 FY27 209 296 Q2 FY26 Q2 FY27 Financial Summary – Q2 FY27 REVENUE Standalone Consolidated INR in crore 35 54 Q2 FY26 Q2 FY27 30 45 Q2 FY26 Q2 FY27 EBITDA Standalone Consolidated INR in crore 9 21 Q2 FY26 Q2 FY27 3 8 Q2 FY26 Q2 FY27 PAT Standalone Consolidated INR in crore ● Delivered robust growth, navigating Middle East geopolitical conflicts, supply chain friction, and feedstock cost inflation ● Led by sustained volume improvement in core segments, anchored by Organolithium's expansion into high-growth emerging applications ● Accelerated scaling in the Battery Chemicals division, Neogen Ionics (NIL), with Q2 FY27 revenue surging to INR 37 crore (vs. INR 5.4 crore in Q2 FY26) ● Achieved strong EBITDA performance despite higher cost base related to Dahej plant rebuild, tolling arrangements, NIL capital expenditure, and elevated input costs ● Consolidated EBITDA reflects the initial fixed-cost absorption at NIL, while revenue scale-up and capacity utilization are still ramping up, setting the foundation for future operating leverage ● Standalone EBITDA Margin for Q2 FY27 – 18.6% ● PAT reflected core operational performance, impacted temporarily by higher interest and depreciation costs from ongoing CAPEX initiatives ● Interest expenses are expected to decline moving ahead, supported by term debt reduction using QIP proceeds and lower borrowing costs following credit rating upgrade
Page 7
7 Revenue break-up – Q2 & H1 FY27 (consolidated) Organic Chemicals Inorganic Chemicals Battery Chemicals 184 238 Q2 FY26 Q2 FY27 349 432 H1 FY26 H1 FY27 24 58 Q2 FY26 Q2 FY27 46 114 H1 FY26 H1 FY27 5 37 Q2 FY26 Q2 FY27 11 56 H1 FY26 H1 FY27
Page 8
8 Financial Table – Profit & Loss Statement (Standalone) Particulars (INR In crore) Q2 FY27 Q2 FY26 Growth (%) H1 FY27 H1 FY26 Growth (%) Revenue 288.0 206.7 39% 540.3 391.3 38% Expenditure 234.3 171.7 36% 438.4 321.6 36% EBITDA 53.7 35.0 54% 101.9 69.6 46% EBITDA Margins 18.6% 16.9% +174 bps 18.9% 17.8% +105 bps Depreciation 7.0 6.4 10% 13.8 11.3 23% Other Income 8.3 4.4 89% 16.2 7.7 111% EBIT (inc. Other Income) 55.0 32.9 67% 104.2 66.0 58% Interest 26.6 20.6 29% 49.7 34.6 43% Profit Before Tax 28.4 12.3 131% 54.6 31.4 74% PBT Margins 9.9% 6.0% +391 bps 10.1% 8.0% +207 bps Exceptional Items 0.0 0.0 NA 0.0 0.0 NA Profit Before Tax (inc. exceptional items) 28.4 12.3 131% 54.6 31.4 74% Tax Expense 7.3 3.0 141% 14.0 7.9 78% Profit After Tax 21.1 9.3 127% 40.6 23.6 72% PAT Margins 7.3% 4.5% +284 bps 7.5% 6.0% +149 bps Earnings Per Share (INR) 7.60 3.53 115% 14.75 8.93 65% * Not annualized
Page 9
9 Financial Table – Profit & Loss Statement (Consolidated) * Not annualized Particulars (INR In crore) Q2 FY27 Q2 FY26 Growth (%) H1 FY27 H1 FY26 Growth (%) Revenue 296.0 208.7 42% 546.3 395.4 38% Expenditure 250.6 178.7 40% 452.7 333.9 36% EBITDA 45.3 30.0 51% 93.6 61.5 52% EBITDA Margins 15.3% 14.4% +95 bps 17.1% 15.5% +158 bps Depreciation 8.8 7.3 20% 17.0 13.1 30% Other Income 4.0 1.9 110% 7.8 3.1 155% EBIT (inc. Other Income) 40.5 24.5 65% 84.4 51.5 64% Interest 27.8 19.5 43% 48.6 32.1 51% Profit Before Tax 12.7 5.2 147% 36.0 19.5 85% PBT Margins 4.3% 2.5% +183 bps 6.6% 4.9% +167 bps Exceptional Items 0.0 0.0 NA 0.0 0.0 NA Profit Before Tax (inc. exceptional items) 12.7 5.2 147% 36.0 19.5 85% Tax Expense 4.5 1.8 152% 10.7 5.8 84% Profit After Tax 8.2 3.4 144% 25.3 13.7 86% PAT Margins 2.8% 1.6% +117 bps 4.6% 3.5% +119 bps Earnings Per Share (INR) 2.96 1.28 131% 9.21 5.18 78%
Page 10
10 Balance Sheet Snapshot (Consolidated) • Standalone: Total Debt at INR 750 crore in H1 FY27; Net Debt at INR 378 crore • Consolidated: Total Debt at INR 1,560 crore in H1 FY27; Net Debt at INR 1,095 crore • Liquid investments (including Fixed Deposits): INR 465 crore as on 30th Sept 2026 Particulars (INR In crore) Sep 30, 2026 Sep 30, 2025 Assets Non-Current Assets 2,004 983 Current Assets 2,001 1,319 Total Assets 4,005 2,302 Liabilities Shareholders’ Funds 1,578 800 Non-Current Liabilities 944 665 Current Liabilities 1,484 837 Total Liabilities & Equity 4,005 2,302
Page 11
11 Key Updates Q2 FY27 (Neogen Chemicals) Insurance Claim Status • Cumulative recoveries stand at INR 164 crore to date, comprising INR 155 crore in on- account insurance claims (including a recent tranche of INR 15 crore in July 2026) and INR 9 crore from salvage realization. Also incurred further incidental charges of INR 1 crore which is claimed as per insurance policy • On Oct 29, 2026, the Company accepted an additional claim amount of Rs. 152 crore from the insurance company, to be released in due course as part-payment of the total receivable • Total on-account claim received/ receivable stands at Rs. 316 crore, inclusive of above accepted claim and salvage scrap sales to date. Fund Raise • Raised INR 600 crore via first-ever QIP; Issue Oversubscribed by 6.5x • QIP attracted strong participation from a diverse mix of renowned domestic and global institutional investors • Proceeds utilized towards debt repayment, fund incremental business requirements and growth opportunities Credit Rating • CRISIL Ratings revised the rating outlook on Neogen Chemicals Limited’s long-term bank facilities (INR 680 crore) and Non-Convertible Debentures (INR 200 Cr) to 'CRISIL A-/Stable' from 'Negative', while reaffirming short-term ratings at 'CRISIL A2+' Expansion of Organolithium manufacturing facility • The board has approved expansion of Organolithium facility at Patancheru, Telangana from 300 MTPA to 600 MTPA with proposed estimated investment of upto INR 45 crore with additional revenue potential of INR 150 to INR 200 crore based on lithium prices
Page 12
12 Update on various expansion initiatives Neogen Ionics’ Proposed Manufacturing Setup Manufacturing locations Land Area Year Planned Capacities Electrolyte Lithium Electrolyte Salts & Additives Dahej SEZ 6,455 m2 FY25 2,000 MT 400 MT FY26 - 1,100 MT FY27 - 1,000 MT Pakhajan, Dahej PCPIR (New site) 264,285 m2 FY27 30,000 MT 3,000 MT Total 270,740 m2 32,000 MT 5,500 MT 12 Battery Chemicals Business Lithium Electrolyte Salts Electrolytes Details of expansion projects at Dahej Current project updates Capacity of 1,500 MTPA for manufacturing Lithium Electrolyte Salts and additives New Capacity of 1,000 MTPA for manufacturing Lithium Electrolyte Salts and Additives • 200 MTPA commissioned; first approval material shipped to the customers • Another 1,000 MTPA commissioned in Q2 FY27; for remaining 300 MTPA, trial production ongoing • 1,000 MT to be commissioned by H2 FY27 • 500 MT additional intermediate to be commissioned in H2 FY27 Plant for manufacturing 2,000 MT of Electrolyte at Dahej facility ● 2,000 MT fully commissioned in FY25
Page 13
13 13 Execution Roadmap & CAPEX • Total estimated project cost for Neogen Ionics’ Dahej Phase 1 and Pakhajan Phase 2 Battery Materials projects stands at INR 1,795 crore (Cumulative CAPEX of INR 1,537 crore to date) o Dahej Phase 1 project cost stands at INR 428 crore with target completion by February 2027, while Pakhajan Phase 2 is budgeted at INR 1,367 crore with completion expected by March 2027 o Project scope and specifications reflect design optimizations following the transition to advanced Japanese technology, alongside enhanced localization of critical sub-components to reduce import dependence and boost long-term operational reliability o Both projects continue to receive strong strategic backing through promoter equity infusion and planned JV partner funding support. Project Updates • Project mechanical completion timelines remain on schedule for Electrolytes (H1 FY27) and Electrolyte Salts (H2 FY27) • Electrolyte: Mechanical assembly is complete and trial runs have begun. Facility validation and product approvals by top domestic battery makers are currently underway to meet rising ACC ecosystem demand. Electrolyte recipes received from 5–6 giga factories, with joint trials currently underway • Active discussions with domestic and international cell manufacturers for electrolyte and lithium salt supply • Lithium Electrolyte Salts: Secured provisional approvals from 5 major international customers and completed final site audits for 3 US-based electrolyte manufacturers. Commercial supply with 2 customers commenced • Execution of a Business Transfer Agreement (BTA) between Neogen Ionics Limited (NIL) and step-down subsidiary Neogen Morita New Materials Limited (NML) to consolidate the lithium-ion electrolyte salt (including LiPF6) undertaking under NML for a lump-sum cash consideration of INR 245 crore on a going concern basis o INR 77 crore already infused by Morita through Preference allotment Update on Battery Chemicals (Neogen Ionics)
Page 14
14 Management Commentary Commenting on the performance, Dr. Harin Kanani, Managing Director, at Neogen Chemicals said: “We have delivered a robust all-round performance, demonstrating remarkable agility despite a challenging macroeconomic backdrop marked by geopolitical conflicts, supply chain friction, feedstock cost inflation, and the temporary unavailability of our Dahej facility. This performance underscores the resilience of our business model, as we swiftly pivoted toward applications with better demand visibility and higher volumes. This momentum was further reinforced by accelerated ramp-up in our Battery Chemicals business. In our Battery Chemicals business, we are transitioning from capital investment to execution and ramp-up phase. We continue to deepen our engagement with leading domestic and global cell manufacturers for supply of electrolyte and lithium salts. With upcoming ACC battery manufacturing plants coming online in India and a progressive shift by US electrolyte manufacturers toward sourcing from non-FEOC suppliers from India, we expect a substantial scale-up in Q4 FY27 and beyond. Our dual facilities at Dahej SEZ and Pakhajan are uniquely positioned to cater to these accelerated requirements, establishing Neogen as one of the largest Indian battery component manufacturers. A key strategic milestone during the period was the successful completion of our maiden QIP, raising INR 600 crore, which was oversubscribed 6.5x, drawing strong participation from marquee domestic and global institutional investors. This overwhelming response serves as a strong endorsement of market confidence in our long-term growth story. The proceeds are being strategically deployed toward de-leveraging our balance sheet, preparing for funding incremental business requirements and growth initiatives. Regarding our Dahej facility insurance claims, we are pleased to share that the majority of the recognized claim amount has already been received through successive on-account payouts. Discussions with the insurers for the remaining balance are progressing constructively, and we expect further settlements in due course as the final assessments conclude. Looking ahead, the outlook for both Neogen Standalone and our Battery Chemicals business remains encouraging as we enter the next phase of transformational growth, supporting India’s vision for self-reliance in the energy storage and advanced battery materials ecosystem. Guided by a clear execution roadmap and supported by a strengthened balance sheet, our full-year consolidated guidance remains on track as we stay focused on driving sustainable growth and delivering long-term value for our stakeholders.” Dr. Harin Kanani Managing Director
Page 15
15 Historical Financial Trends (Consolidated) 336 487 686 691 778 862 0 100 200 300 400 500 600 700 800 900 1000 FY21 FY22 FY23 FY24 FY25 FY26 Net Revenue from Operations* (INR crore) 65 87 112 110 136 13719.1% 17.8% 16.3% 15.9% 17.5% 15.9% 0.0% 5.0% 10.0% 15.0% 20.0% 25.0% 0 20 40 60 80 100 120 140 160 FY21 FY22 FY23 FY24 FY25 FY26 EBITDA (INR crore) Margin (%) 31 45 50 36 35 29 9.3% 9.2% 7.3% 5.2% 4.5% 3.3% 0.0% 1.0% 2.0% 3.0% 4.0% 5.0% 6.0% 7.0% 8.0% 9.0% 10.0% 0 10 20 30 40 50 60 FY21 FY22 FY23 FY24 FY25* FY26 PAT (INR crore) Margin (%) 183 439 483 760 789 816 215 99 265 378 530 1295 0 200 400 600 800 1000 1200 1400 FY21 FY22 FY23 FY24 FY25 FY26 Networth (INR crore) Net Debt (INR crore) * Includes Exceptional Item of INR 14.08 crore on account of damage to certain property, plant & equipment, inventory and estimated cost of incidental charges due to fire incident at the Dahej plant 15
Page 16
16 Seasonal Variance Factors Neogen’s business has some seasonal drivers, due to which the Company tends to deliver stronger financial performance in the second half of the financial year (October to March) due to strong demand from Europe which typically scales up in October- November and further accelerates from January after the holiday season Demand for Lithium-based chemicals tends to be strong in Q4 as demand from the HVAC segment, a key usage area, is linked to capital expenditure that enjoys 100% depreciation benefits for air-conditioning/ cooling machines Demand from the agrochemicals segment is linked to the crop cycle and is stronger during H2 Consequently, investors are urged to compare financial performance of each quarter only with that of the corresponding quarter previous year to evaluate business progress on a like-to-like basis
Page 17
17 Introduction to Neogen Chemicals
Page 18
18 Neogen Chemicals – At a Glance 313 Products developed by in-house R&D 7 Manufacturing Sites + 2 R&D Facilities* Infrastructure 1,058* Employees (of which 13% of workforce is in R&D team) ISO 9001:2015, ISO 14001:2015, ISO 20400:2017 & ISO 45001:2018 and others* Manufacturing units certified on Quality & SHE management systems 816* Net worth : March 31, 2026 (INR crore) 21%* 5-year Revenue CAGR Leading manufacturer of Bromine and Lithium-based specialty chemicals, operating since 1991 – Over 30 Years of Strong History Largest Importer of Lithium Carbonate for last 3 decades – Strong Relationship with Global Leading Lithium Miners & Processors Customers across multiple industries including Pharma, Engineering, Battery Chemicals and Agrochem Growing contribution from Custom Synthesis and Contract Manufacturing Promoters are technocrats with substantial domain expertise; cumulative experience of more than six decades * Consolidated
Page 19
19 Evolution of Neogen Chemicals 1970’s to 1991 Pre-Neogen • Mr. HT Kanani is a Chemical Engineer from IIT Bombay. His association with Bromine chemistry started in the early 1970s • Set up one of India’s first Bromine plants using indigenous technology at Gujarat o Plant was later destroyed in 1970s by flooding in Morbi due to dam collapse o Mr. Kanani worked as a consultant for setting up Bromine and other manufacturing units till 1984 to recover these losses • In 1985, started manufacturing Bromine derivatives from a 600 sq. ft. plant to start making n-propyl bromide and lithium bromide 1991 to 2016 Site I • ‘Neogen Chemicals’ commenced business operations in 1991, at Mahape, Navi Mumbai manufacturing a few Bromine Compounds and Lithium Compounds • Set up dedicated R&D and hired first PhD scientist in 2001 • Capacity expansions at Mahape plant took place in 2000, 2007 and 2012 • Dr. Harin (now MD) re-joined Neogen Chemicals in 2008 after pursuing his PhD in Chemical Engineering from University of Maryland, USA • Reached Rs. 100 crore by FY16 from Mahape plant 2016 to 2019 Site I & II • Acquired Solaris ChemTech Industries’ Bromine derivatives plant at Vadodara in 2016 via slump sale o Included ~157,827 sq. meters of land, plant and machinery, ~50 trained manpower and several technologies developed in-house • Turnover more than tripled to Rs. 300 crore in FY19 2020 to 2026 Multiple Sites • Doubled Inorganic Chemicals capacity from 1,200 MT to 2,400 MT • Raised ~INR 225 crore through preferential allotment in Dec 2021 • Signed agreement with MUIS, Japan to acquire manufacturing technology license for electrolytes in India • Acquired 100% stake in BuLi Chem to offer organolithium products • Raised ~ INR 253 crore through preferential allotment in Nov 2023 • Neogen Ionics acquired 65 acres of land in Pakhajan, Dahej PCPIR, for dedicated Battery Materials project • Neogen Ionics commences sales of Lithium Salts and Electrolytes from Dahej SEZ plant • Promoter infused INR 161 crore through preferential allotment • Raised INR 600 crore via first-ever QIP; Issue Oversubscribed by 6.5x
Page 20
20 Leading manufacturer of Bromine and Lithium-based specialty chemicals since 1989 20 1989-2000 2001-2015 2016 2019 2020 2021 2023 2024 2025 2026 Major Milestones • Incorporation as a private limited company • Started operations with Lithium salts and organic bromide at Mahape • Increase in capacity • Conversion to public limited company • Started manufacturing specialty bromine compounds • Increased reactor capacity at Mahape to 45,000 litres • Acquired land in Dahej SEZ • Achieved turnover of ₹100 crore • Acquired manufacturing operations of Solaris Chemtech Limited at Karakhadi, Gujarat (Vadodara) • Raised INR 132 crore through initial public offering (IPO) and Offer for sale • Increased the capacity of Inorganic Chemicals to 2,400 MT through Greenfield expansion at Dahej, Gujarat • Increased Organic Chemicals reactor capacity to 407,000 liters • Raised ~ INR 225 crore through preference share allotment • Signed licensing agreement with MUIS, Japan • Acquired 100% stake in BuLi Chem • Raised ~INR 253 crore through preferential allotment • Neogen Ionics (NIL) acquired 65 acres of land in Pakhajan, Dahej PCPIR • Approved Merger of Buli Chemicals with Neogen Chemicals • NIL begins sales of Lithium Salts & Electrolytes from Dahej SEZ plant • Expanded Patancheru plant capacity (BuLi Chem) from 120 MT active to 300 MT active • Incorporated 100% subsidiary of NIL namely, ‘Neogen Morita New Materials Limited • Raised INR 200 crore via NCDs • Execution of JV: Neogen Ionics (NIL) and Morita Investment (MIL) • Promoter infused INR 161 crore through preferential allotment • Raised INR 600 crore via first- ever QIP; Issue Oversubscribed by 6.5x
Page 21
21 Organic Chemicals Bromine Compounds Organic compounds containing bromine, chlorine, fluorine, iodine-based, combinations thereof and others including grignard reagents Organolithium N Butyl Lithium and other organolithium products using highly reactive Lithium metal; key reagents for Lithiation reaction Advanced Intermediates Combining bromination with other chemistries to create forward-integrated value-added products Custom Synthesis & Contract Manufacturing Products developed for specific customers. Process know-how and technical specifications are developed in-house End User Industries Pharmaceuticals Agro chemicals Flavors & Fragrances Semi conductors Electronic Chemicals Inorganic Chemicals End User Industries The portfolio includes specialty, inorganic lithium-based chemical products which find applications across multiple industries Eco-friendly VAM for cooling air/ water/ process equipment Pharmaceuticals Specialty Polymers Battery Chemicals Select Clientele Business Overview
Page 22
22 Core Strategic Strengths Strong Leadership Team with Deep Domain Expertise in Specialty Chemistry Diversified Global Customer Base Integrated Manufacturing & Scalable Infrastructure Strong R&D and Innovation Capability Pioneered in Advanced Battery Materials Manufacturing Strategic Partnerships • Over 35 years of experience in complex chemistry • Strong capabilities in bromination, lithiation and custom synthesis • Focus on high-entry- barrier, innovation-led applications • Presence across 36 countries • Strong exposure to North America, Europe, the Middle East, Asia, Japan, China and Korea • Balanced domestic export revenue mix • 7 manufacturing facilities across four locations in India • Flexible production setup enhancing multiple chemistries • Significant brownfield and greenfield expansion potential • Dedicated 2 R&D centers with skilled technical teams • Continuous focus on process improvement and cost efficiency • Customer-specific product development capabilities • Early mover in lithium- ion battery materials in India • Investments in electrolytes, lithium salts and additives • Large-scale expansion underway through Neogen lonics • Collaborations with Japanese technology leaders • Access to advanced processes and product know-how • Strengthening global competitiveness and market reach 22
Page 23
23 Experienced Leadership Team • Holds a bachelor’s degree in chemical engineering from IIT, Bombay and a Master’s degree and a doctorate in chemical engineering from the University of Maryland • Served as a research fellow at the University of Maryland, where he has published 4 first author manuscripts in the field of chemical engineering • Joined NCL in 2008 and is on the Board since 2017 • Has previously worked with companies such as Asian Paints India and as a senior research scientist at Pioneer Hi-Bred International Inc. (DuPont Subsidiary) in the United States Managing Director Neogen Chemicals Limited (NCL & NIL) Dr. Harin Kanani Mr. Anurag Surana, Non-Executive Chairman, NCL • Holds a bachelor’s degree in commerce with Honours from the University of Delhi • Rich experience of over 35 years in the Specialty Chemical Industry • Non-Executive/ Independent Director on the Board of several leading Specialty Chemical companies • A well-known personality in the Agrochemical and specialty chemical industry in India, Europe and Japan • To help elevate growth through sound corporate governance and translating strategy into reality via a culture of agile execution and accountability Mr. Sanjay Mehta Non-Executive Chairman, NIL • An eminent Chartered Accountant with over 45 years’ experience • Successfully managed the growth of M/s Akkad Mehta & Co. LLP • Carved his niche as a thorough professional by consistently delivering solutions out of the box that are technically sound, innovative and implementable for the clients • Brings in the best Governance practices and also provide guidance on compliance to the NIL Leadership Team Dr. Haridas Kanani, Chairman Emeritus • Holds a bachelor’s degree in chemical engineering from IIT, Bombay • Established 1st Bromine Plant of India with Indigenous technology • Guided Neogen as Chairman and Managing Director from 1989 to 2025 - over 35 years, growing 750x, exporting to 28 countries from multiple locations. • Appointed as ‘Chairman Emeritus’ after completing 80 years of age – to continue providing valuable guidance and mentorship to Neogen Chemicals Mr. Shyamsunder Upadhyay Whole time Director • Holds a master’s degree in science from Vikram University, Ujjain • 41 years of work experience in the field of chemicals • Oversees maintenance, projects, logistics, administration and engineering store in the company Mr. TCN Sai Krishnan Executive Director • Holds MBA degree with Chemical engineering • 33 years of experience in Manufacturing, Projects, Procurement & Supply Chain with specialty chemicals, petrochemicals, paints, inks & FMCG industries Mr. Gopikrishnan Sarathy Chief Financial Officer • Associate member of the Institute of Chartered Accountants of India, and Diploma in IFRS from ACCA UK • Over 25 years of diverse experience in the field of Finance & Accounts, Strategic Planning and Budgeting, M&A and Investor relations among others Mr. Kirit Chauhan President – HR & Admin • Holds a degree in M.L.W., PGDHRM with a focus on Labour Laws from South Gujarat University • Extensive experience in human resources and administration Mr. B P Pant President – New Prod. • Holds M Sc degree in Organic Chemistry from the Department of Chemistry at Pune University • Over 2 decades of extensive work experience in the chemical industry, with focus on business development Mr. Hideji Hosoda President – Neogen Japan • Veteran with more than 4 decades of experience and a well-known person in the agrochemical industry in Japan • Plays a very active role in Advising Neogen on all strategic initiatives in the Battery Chemical and other Specialty Chemical business in Japan 23
Page 24
24 Strong Manufacturing Infrastructure – Neogen Chemicals Factory Land Area Land Utilisation Capacity Certifications of Manufacturing Facilities Electrolyte Lithium Electrolyte Salts & Additives Mahape (Since 1991) 4,045 m2 100% 69 m3 9 m3 ISO 9001:2015, ISO 26000:2010, ISO 31000:2018, ISO 37001:2016 from Bureau Veritas Vadodara (Since 2017) 161,874 m2 20% 111 m3 - ISO 9001:2015, ISO 14001:2015, ISO 45001:2018, ISO 26000:2010, ISO 31000:2018, ISO 37001:2016 from Bureau Veritas Dahej (Since 2020)* 43,374 m2 - Earlier 258 m3 Earlier 30 m3 ISO 9001:2015, ISO 14001:2015, ISO 45001: 2018, ISO 26000:2010, ISO 31000:2018, ISO 37001:2016 ISO 20400:2017 from Bureau Veritas and also, GMP (Good Manufacturing Practices) certified by SGS Total 209,293 m2 438 m3 39 m3 Patancheru (May 2023) 16,187 m2 50% 300 MTA - ISO 9001:2015, ISO 14001: 2015, ISO 45001: 2018 from Bureau Veritas *Following the fire incident at Dahej plant in March 2025, the current capacity is unavailable. However, a replacement plant of the same capacity is currently under construction, expected to be operational soon Quality Control and Quality Assurance • Dedicated QC and QA team in place monitoring the entire manufacturing process at all stages right from initial testing stage to the final product • Implemented current good manufacturing practice (cGMP) prescribed by the US FDA as applicable for intermediates World-class operational practices • Zero Liquid Discharge, significantly reducing water usage • Focus on compliance with stringent quality and EHS norms 24
Page 25
25 Driving Innovation Through R&D 1 2 3 4 5 Established two R&D units 133-member dedicated R&D team, including 11 Ph. D. Focus on R&D to drive sustained growth; to continue to deploy resources MD actively involved and spend significant time overseeing the functioning of R&D divisions Post commissioning of dedicated R&D units in 2001, the product portfolio has grown from 20 products in 2001 to 313 products in Q2 FY27 20 313 PRODUCTS Portfolio growth surge from 2001 to Q2 FY27
Page 26
26 Neogen’s Global Footprint USA Europe Middle East China Korea Japan 34% Japan Subsidiary: • Neogen Chemicals Japan Corporation Limited • Serves as Neogen’s key arm to deepen strategic ties with Japanese companies. Representative Offices: • Germany • Korea Export sales of in Q2 FY27 26
Page 27
27 Industry Tailwinds : Neogen’s Strategic Positioning Growth Driver Opportunity for Neogen Redefining Global Supply Chains Positioned as a preferred alternative manufacturing partner for global customers across specialty chemicals, pharma intermediates, agrochemicals, and battery materials. Specialty Chemicals Demand Capturing sustained demand across key end-user sectors (agro, pharma, auto, electronics, clean energy) and leveraging India’s growing electronics and semiconductor manufacturing ecosystem. Supply Chain Localisation Driving Import Substitution: Global maritime disruptions and long transit times are accelerating the pivot away from single-region sourcing, positioning Neogen to supply domestically produced specialty chemicals, pharma and agrochemical intermediates. Advanced Materials Demand Supplying ultra-high-purity electronic chemicals and custom manufacturing solutions to meet expanding demand in semiconductors, electronics, and advanced manufacturing. Climate Transition Delivering sustainable green chemistry solutions and advanced battery materials to support accelerating global decarbonization and ESG priorities. EV Transition & Energy Storage Capitalizing on EV and energy storage growth via Neogen Ionics, manufacturing high-purity electrolytes and lithium salts supported by India’s PLI and FAME schemes, making India self reliant. Government Policy Support (MOOWR Scheme) Leveraging the MOOWR scheme via customs duty deferment and duty-free exports to enhance Neogen Ionics’ global cost competitiveness.
Page 28
28 Industry Overview Lithium-ion Batteries
Page 29
29 Strong Opportunities in Lithium Battery Sector – India Government’s PLI Scheme for ACC Batteries: Backed by an outlay of ₹18,100 crore to build 50 GWh of Advanced Chemistry Cell manufacturing capacity, the scheme mandates scaling domestic value addition to 60% within 5 years to drive a localized EV ecosystem Direct investment of around INR 45,000 crore in ACC Battery storage manufacturing projects Rebidding: Govt. has invited global bids to establish 10 GWh of giga-scale Advanced Chemistry Cell (ACC) battery manufacturing capacity with a maximum outlay of INR 3,620 crore under the PLI scheme Proposed PLI for battery components will incentivize domestic cell manufacturers to localize their raw material sourcing, accelerating commercial off-take for Neogen’s electrolyte and lithium salt capacities Total 63.4 GWh under various stages of development Out of the total 63.4 GWh, 26.7 GWh is scheduled for commissioning in 2026 Overall, 13+ players announced manufacturing capacities 220+ GWh of total capacities announced 3.53 GWh of total installed capacities 0 50 100 150 200 250 2025 2027 2032 Battey Demand (GWH)
Page 30
30 Strong Opportunities in Lithium Battery Sector – Global Demand Estimates for the Global Market (By 2030) 1,500 3,000 1,500 0 500 1,000 1,500 2,000 2,500 3,000 3,500 China & Non-China Total Estimated Battery requirement (GWh) China Non-China 1,800 2,925 1,125 0 500 1,000 1,500 2,000 2,500 3,000 3,500 China & Non-China Total Estimated Electrolyte demand (KT) China Non-China 225 366 141 0 50 100 150 200 250 300 350 400 China & Non-China Total Estimated Lithium Salt demand (KT) China Non-China 30 Demand for non-Chinese Electrolyte and Lithium Salts is projected to increase substantially by 2030 Manufacturing of Lithium-Ion battery cells is ramping up in India, with major battery producers actively advancing project execution, driving demand for Electrolyte and captive consumption of Lithium Salts To secure the US Govt. Tax credit (45X), U.S. LiB cell producers must adhere to Foreign Entity of Concern (FEOC) guidelines. This necessitates a shift to non-FEOC suppliers by 2027. Consequently, most international customers are proactively accelerating their supplier transition to non-FEOC sources in different phases during 2026 to mitigate compliance risk and ensure continued eligibility for the credit with full transition expected by 2027
Page 31
31 Way Forward Augment the capacities of Organic and Inorganic Chemicals Enhance focus on CSM & Advanced Intermediates through portfolio expansion Expand capabilities in adjacent high- end complex chemistries Deep inroads in the Battery Materials segment Leverage strong R&D expertise to introduce innovative offerings
Page 32
32 Driving Sustainable Growth Through ESG Excellence 32 Clean Energy Focus Dedicated CAPEX via wholly owned subsidiary Neogen Ionics Limited for manufacturing high- purity electrolytes and Lithium salts, backed by sustainable energy integration and green chemistry principles Robust Oversight ESG risks are formally integrated into the mandate of the Risk Management Committee, ensuring sustainability considerations drive long-term business strategy Ethical Foundation Comprehensive policies covering all 9 principles of NGRBC extended to value chain partners. Zero complaints reported regarding corruption, bribery, or human rights violations Strengthening Corporate Governance Aligned with best governance practices, separating Chairman and Managing Director roles. Headed by Mr. Anurag Surana as Non-Executive Chairman, with founder Mr. Haridas Kanani as Chairman Emeritus
Page 33
33 CSR Approach: Focusing On The Greater Good Shaping an Inclusive and Sustainable Future CSR Focus Areas (FY26) INR 14.97 Lakh INR 11.26 Lakh INR 56.01 Lakh INR 34.10 Lakh INR 20.95 Lakh Environment Healthcare Education Water Conservation & Natural Resource Management Rural Development and Women Empowerment 33 Securing the EcoVadis Silver Medal for 2026 highlights Neogen's continued progress in ESG and its firm commitment to sustainability and responsible business practices.
Page 34
34 Contact Us About Neogen Chemicals Limited Incorporated in 1989, Neogen Chemicals Ltd. (NSE Code: NEOGEN; BSE Code: 542665) is India’s one of the largest, oldest and most diverse manufacturers of Bromine-based and Lithium-based specialty chemicals. Products Its specialty chemicals product offerings comprise Organic as well as Inorganic chemicals. Its products are used in pharmaceuticals, agrochemicals, semi-conductors, engineering polymers, electronic chemicals, construction chemicals, and aroma chemicals, flavours and fragrances, dyes and specialty polymers, and refrigerant for Vapour Absorption Machine and with new upcoming usage in lithium-ion battery materials for energy storage and Electric Vehicles (EV) application. Over the years, Neogen has expanded its range of products and at present, manufactures an extensive range of specialty chemicals which find application across various industries in India and the world. It has a product portfolio of over 313 products. In addition to manufacturing specialty chemicals, Neogen also undertakes custom synthesis and contract manufacturing where the product is developed and customised primarily for a specific customer, but process know- how and technical specifications are developed in-house. The Company has announced plans to utilise its three decades of experience in Lithium Chemistry to manufacture Lithium-Ion battery materials with an initial investment plan to manufacture electrolytes and Lithium electrolyte salts. Facilities The Company operates out of its four manufacturing facilities located in Mahape, Navi Mumbai in Maharashtra, Dahej SEZ, Bharuch, Karakhadi, Vadodara in Gujarat and Patancheru, Sangareddy, Telangana (In January 2025, Buli Chemicals India Private Limited was merged with Neogen Chemicals, their facility was located in Patancheru). Neogen Chemicals Limited also has a wholly owned subsidiary – Neogen Ionics Limited, dedicated to projects related to battery materials. Neogen Ionics Limited is the first manufacturer in India to commercially supply lithium-ion battery electrolytes at commercial scale to a giga-scale battery manufacturing facility. 34 For further information, please contact: Gopikrishnan Sarathy Neogen Chemicals Ltd. Email: investor@neogenchem.com Nishid Solanki CDR India Tel: +91 98203 68989 Email: nishid@cdr-india.com
Page 35
35 Thank You